Publication
Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)
Journal Paper/Review - Mar 15, 2018
Untch Michael, Loibl Sibylle, Nekljudova Valentina, Fehm Tanja, Hauschild Maik, Blohmer Jens-Uwe, Kunz Georg, Jackisch Christian, Solbach Christine, Huober Jens, Hanusch Claus, Eggemann Holm, Tesch Hans, Fasching Peter A, Rezai Mahdi, Schem Christian, Gerber Bernd, von Minckwitz Gunter, GBG and the AGO-B Study Group
Untch, Michael
88
0
von Minckwitz, Gunter
59
0
Gerber, Bernd
49
0
Schem, Christian
16
0
Rezai, Mahdi
15
0
Fasching, Peter A
74
0
Tesch, Hans
47
0
Eggemann, Holm
3
0
Hanusch, Claus
42
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Solbach, Christine
24
0
Jackisch, Christian
69
0
Kunz, Georg
5
0
Blohmer, Jens-Uwe
48
0
Hauschild, Maik
5
0
Fehm, Tanja
31
0
Nekljudova, Valentina
35
0
Loibl, Sibylle
84
0
GBG and the AGO-B Study Group,
1
0